The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Oral Session

Oral Session 3-10B MM: Novel therapeutic approaches

Sun. Oct 14, 2018 9:40 AM - 10:40 AM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Masuzu Ueda (Division of Hematology, Depaertment of Internal Medicine, Jichi Medical University, Japan)

[OS3-10B-2] Bi-allelic loss of FAM46C by CRISPR/CAS9 system enhances myeloma cell growth

Jo Kanasugi1, Ichiro Hanamura1, Akinobu Ota2, Sivasundaram Karnan2, Shohei Mizuno1, Kaori Uchino1, Ayano Nakamura1, Soichi Takasugi1, Tomohiro Horio1, Mineaki Goto1, Mayuko Goto1, Miyuki Takahashi1, Hidesuke Yamamoto1, Masaya Watarai1, Hidetsugu Mihara1, Takayuki Nakayama4, Hidehumi Kato5, Susumu Suzuki3, Yoshihisa Kodera6, Yoshitaka Hosokawa2, Ryuzo Ueda3, Akiyoshi Takami1 (1.Division of Hematology, Aichi Medical University, Nagakute, Japan, 2.Department of Biochemistry, Aichi Medical University, Nagakute, Japan, 3.Department of Tumor Immunology, Aichi Medical University, Nagakute, Japan, 4.Central Clinical Laboratory, Aichi Medical University, Nagakute, Japan, 5.Blood Transfusion Department, Aichi Medical University Hospital, Nagakute, Japan, 6.Department of Promotion for Blood and Marrow Transplantation)

Abstract password authentication.
Password is written on a program and abstract book.

Password